BSE Live
Oct 14, 11:19Prev. Close
931.70
Open Price
925.00
Bid Price (Qty.)
919.20 (5)
Offer Price (Qty.)
920.65 (23)
NSE Live
Oct 14, 11:19Prev. Close
930.75
Open Price
929.00
Bid Price (Qty.)
919.05 (50)
Offer Price (Qty.)
919.55 (1)
Cash Flow of Alivus Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 654.13 | 631.29 | 628.61 | 564.93 | 470.94 | |
Net CashFlow From Operating Activities | 391.52 | 413.52 | 313.40 | 597.59 | 388.11 | |
Net Cash Used In Investing Activities | -615.65 | -116.48 | -154.15 | -122.23 | -68.73 | |
Net Cash Used From Financing Activities | -6.23 | -279.44 | -387.59 | -78.80 | -213.78 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -230.35 | 17.59 | -228.33 | 396.56 | 105.60 | |
Cash And Cash Equivalents Begin of Year | 301.41 | 283.82 | 512.16 | 115.60 | 10.00 | |
Cash And Cash Equivalents End Of Year | 71.06 | 301.41 | 283.82 | 512.16 | 115.60 |
05.08.2025
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y
25.10.2024
Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y
26.07.2024
Glenmark Life Standalone June 2024 Net Sales at Rs 588.62 crore, up 1.76% Y-o-Y
26.04.2024
Glenmark Life Standalone March 2024 Net Sales at Rs 536.60 crore, down 13.64% Y-o-Y